Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies.

Skolarus TA, Hawley ST, Forman J, Sales AE, Sparks JB, Metreger T, Burns J, Caram MV, Radhakrishnan A, Dossett LA, Makarov DV, Leppert JT, Shelton JB, Stensland KD, Dunsmore J, Maclennan S, Saini S, Hollenbeck BK, Shahinian V, Wittmann DA, Deolankar V, Sriram S

Open source

DOI: 10.1186/s43058-024-00576-x
Published: 2024 Apr 9
Container: Implementation science communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s43058-024-00576-x,
  title = {Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies.},
  author = {Skolarus TA and Hawley ST and Forman J and Sales AE and Sparks JB and Metreger T and Burns J and Caram MV and Radhakrishnan A and Dossett LA and Makarov DV and Leppert JT and Shelton JB and Stensland KD and Dunsmore J and Maclennan S and Saini S and Hollenbeck BK and Shahinian V and Wittmann DA and Deolankar V and Sriram S},
  year = {2024},
  journal = {Implementation science communications},
  doi = {10.1186/s43058-024-00576-x},
  url = {https://doi.org/10.1186/s43058-024-00576-x}
}

RIS

TY  - JOUR
TI  - Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies.
AU  - Skolarus TA
AU  - Hawley ST
AU  - Forman J
AU  - Sales AE
AU  - Sparks JB
AU  - Metreger T
AU  - Burns J
AU  - Caram MV
AU  - Radhakrishnan A
AU  - Dossett LA
AU  - Makarov DV
AU  - Leppert JT
AU  - Shelton JB
AU  - Stensland KD
AU  - Dunsmore J
AU  - Maclennan S
AU  - Saini S
AU  - Hollenbeck BK
AU  - Shahinian V
AU  - Wittmann DA
AU  - Deolankar V
AU  - Sriram S
PY  - 2024
JO  - Implementation science communications
DO  - 10.1186/s43058-024-00576-x
UR  - https://doi.org/10.1186/s43058-024-00576-x
ER  -

APA

TA, S., ST, H., J, F., AE, S., JB, S., T, M., J, B., MV, C., A, R., LA, D., DV, M., JT, L., JB, S., KD, S., J, D., S, M., S, S., BK, H., V, S., DA, W., V, D., & S, S. (2024). Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies.. Implementation science communications. https://doi.org/10.1186/s43058-024-00576-x

Source records

pubmed · retrieved 2026-09-26T07:10:26.929Z